TRVI
NASDAQ · Pharmaceuticals
Trevi Therapeutics Inc
$17.21
+0.84 (+5.13%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+27.4% upside
Low Target
$18.04
Average Target
$21.93
High Target
$33.12
Current Price
$17.21
Current
$17.21
$17.21
Target
$21.93
$21.93
$18.04
$21.93 avg
$33.12
Scenario Analysis
Bear Case
$18.04
4.8%
Low target
Base Case
$21.93
+27.4%
Avg target
Bull Case
$33.12
+92.4%
High target
Risk/Reward
19.2x
Highly favorable
Price in Context
52-Week High
$17.61
-2.3% from high
52-Week Low
$5.41
+218.1% from low
Target vs 52W High
$21.93
+24.5% vs high
Peer Consensus — Pharmaceuticals